Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study - Moreira, Thais G.; Matos, Kimble T. F.; De Paula, Giovana S.; Santana, Thais M. M.; Da Mata, Raquel G.; Pansera, Fernando C.; Cortina, Andre S.; Spinola, Marcelle G.; Baecher-Allan, Clare M.; Keppeke, Gerson D.; Jacob, Jules; Palejwala, Vaseem; et al. (Frontiers in Immunology, 2022)